Mortier GR, Cohn DH, Cormier-Daire V, Hall C, Krakow D, Mundlos S, et al. Nosology and classification of genetic skeletal disorders: 2019 revision. Am J Med Genet Part A. 2019;179:2393–419.

Article  PubMed  Google Scholar 

Camurati M. Di un raro caso di osteite simmetrica erditaria degli arti inferiori. Chir Organ Mov. 1922;6:662–5.

Google Scholar 

Engelmann G. Ein Fall von Osteopathia Hyperosteotica (sclerotisans) multiplex infantilis. Fortschr Rontgenstr. 1929;39:1101–6.

Google Scholar 

Janssens K, Vanhoenacker F, Bonduelle M, Verbruggen L, Van Maldergem L, Ralston S, et al. Camurati–Engelmann disease: review of the clinical, radiological, and molecular data of 24 families and implications for diagnosis and treatment. J Med Genet. 2006;43:1–11.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ghadami M, Makita Y, Yoshida K, Nishimura G, Fukushima Y, Wakui K, et al. Genetic mapping of the Camurati–Engelmann disease locus to chromosome 19q13.1-q13.3. Am J Hum Genet. 2000;66:143–7.

Article  CAS  PubMed  Google Scholar 

Kinoshita A, Saito T, Tomita H, Makita Y, Yoshida K, Ghadami M, et al. Domain-specific mutations in TGFB1 result in Camurati–Engelmann disease. Nat Genet. 2000;26:19–20.

Article  CAS  PubMed  Google Scholar 

Hecht JT, Blanton SH, Broussard S, Scott A, Rhoades Hall C, Milunsky JM. Evidence for locus heterogeneity in the Camurati–Engelmann (DPD1) syndrome. Clin Genet. 2001;59:198–200.

Article  CAS  PubMed  Google Scholar 

Nishimura G, Nishimura H, Tanaka Y, Makita Y, Ikegawa S, Ghadami M, et al. Camurati–Engelmann disease type II: progressive diaphyseal dysplasia with striations of the bones. Am J Med Genet. 2002;107:5–11.

Article  PubMed  Google Scholar 

Wang Z, Horemuzova E, Iida A, Guo L, Liu Y, Matsumoto N, et al. Axial spondylometaphyseal dysplasia is also caused by NEK1 mutations. J Hum Genet. 2017;62:503–6.

Article  CAS  PubMed  Google Scholar 

McKenna A, Hanna M, Banks E, Sivachenko A, Cibulskis K, Kernytsky A, et al. The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res. 2010;20:1297–303.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang K, Li M, Hakonarson H. ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res. 2010;38:e164–e164.

Article  PubMed  PubMed Central  Google Scholar 

Yang J, Yan R, Roy A, Xu D, Poisson J, Zhang Y. The I-TASSER Suite: protein structure and function prediction. Nat Methods. 2015;12:7–8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shi M, Zhu J, Wang R, Chen X, Mi L, Walz T, et al. Latent TGF-β structure and activation. Nature. 2011;474:343–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Schymkowitz J, Borg J, Stricher F, Nys R, Rousseau F, Serrano L. The FoldX web server: an online force field. Nucleic Acids Res. 2005;33:W382–W388.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Janssens K, ten Dijke P, Ralston SH, Bergmann C, Van Hul W. Transforming growth factor-β1 mutations in Camurati–Engelmann disease lead to increased signaling by altering either activation or secretion of the mutant protein. J Biol Chem. 2003;278:7718–24.

Article  CAS  PubMed  Google Scholar 

Okita K, Matsumura Y, Sato Y, Okada A, Morizane A, Okamoto S, et al. A more efficient method to generate integration-free human iPS cells. Nat Methods. 2011;8:409–12.

Article  CAS  PubMed  Google Scholar 

Fukuta M, Nakai Y, Kirino K, Nakagawa M, Sekiguchi K, Nagata S, et al. Derivation of mesenchymal stromal cells from pluripotent stem cells through a neural crest lineage using small molecule compounds with defined media. PLoS ONE. 2014;9:e112291.

Article  PubMed  PubMed Central  Google Scholar 

Walton KL, Makanji Y, Chen J, Wilce MC, Chan KL, Robertson DM, et al. Two distinct regions of latency-associated peptide coordinate stability of the latent transforming growth factor-beta1 complex. J Biol Chem. 2010;285:17029–37.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Saito T, Kinoshita A, Yoshiura KI, Makita Y, Wakui K, Honke K, et al. Domain-specific mutations of a transforming growth factor (TGF)-β1 latency-associated peptide cause Camurati–Engelmann disease because of the formation of a constitutively active form of TGF-β1. J Biol Chem. 2001;276:11469–72.

Article  CAS  PubMed  Google Scholar 

Sporn MB, Roberts AB, Wakefield LM, Assoian RK. Transforming growth factor-β: biological function and chemical structure. Science. 1986;233:532–4.

Article  CAS  PubMed  Google Scholar 

Derynck R, Akhurst RJ, Balmain A. TGF-β signaling in tumor suppression and cancer progression. Nat Genet. 2001;29:117–29.

Article  CAS  PubMed  Google Scholar